{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:30:17Z","timestamp":1785310217732,"version":"3.55.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bioorg.2023.107042","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:06:33Z","timestamp":1702724793000},"page":"107042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020\u20132023)"],"prefix":"10.1016","volume":"143","author":[{"given":"Nitish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komalpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekampreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Mohinder Singh","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.107042_b0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","article-title":"Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?","volume":"118","author":"Baker","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2023.107042_b0010","doi-asserted-by":"crossref","unstructured":"D.S. Newcombe, A Brief History of Gout, in: Gout, Springer London, London, 2013: pp. 1\u20138. https:\/\/doi.org\/10.1007\/978-1-4471-4264-5_1.","DOI":"10.1007\/978-1-4471-4264-5_1"},{"key":"10.1016\/j.bioorg.2023.107042_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40674-015-0012-9","article-title":"Gout and hyperuricemia: an historical perspective","volume":"1","author":"MacKenzie","year":"2015","journal-title":"Curr. Treatm. Opt. Rheumatol."},{"key":"10.1016\/j.bioorg.2023.107042_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.11613\/BM.2012.007","article-title":"Uric acid as one of the important factors in multifactorial disorders - facts and controversies","volume":"22","author":"Pasalic","year":"2012","journal-title":"Biochem. Med. (zagreb)."},{"key":"10.1016\/j.bioorg.2023.107042_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rdc.2006.02.005","article-title":"Hyperuricemia and associated diseases","volume":"32","author":"Becker","year":"2006","journal-title":"Rheumatic Dis. Clin. North America"},{"key":"10.1016\/j.bioorg.2023.107042_b0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bioorg.2023.107042_b0035","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","article-title":"Gout and hyperuricaemia in the USA: Prevalence and trends","volume":"58","author":"Singh","year":"2019","journal-title":"Rheumatology (United Kingdom)."},{"key":"10.1016\/j.bioorg.2023.107042_b0040","unstructured":"Arthritis-Related Statistics | Data and Statistics | Arthritis | CDC, (2023). https:\/\/www.cdc.gov\/arthritis\/data_statistics\/arthritis-related-stats.htm (accessed August 30, 2021)."},{"key":"10.1016\/j.bioorg.2023.107042_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2015.08.087","article-title":"The treatment of hyperuricemia","volume":"213","author":"Gliozzi","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2023.107042_b0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1517\/13543776.2011.577417","article-title":"Xanthine oxidase inhibitors: a patent survey","volume":"21","author":"Kumar","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.107042_b0055","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3390\/nu14173525","article-title":"Gout and diet: a comprehensive review of mechanisms and management","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2023.107042_b0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1751-7133.2011.00262.x","article-title":"Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition","volume":"18","author":"Harzand","year":"2012","journal-title":"Congestive Heart Failure"},{"key":"10.1016\/j.bioorg.2023.107042_b0065","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2023.107042_b0070","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s00044-020-02589-2","article-title":"Design, synthesis and biological evaluation of novel indolinedione\u2013coumarin hybrids as xanthine oxidase inhibitors","volume":"29","author":"Gulati","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.107042_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.comptc.2023.114262","article-title":"Hybridization of molecular docking studies with machine learning based QSAR model for prediction of xanthine oxidase activity","volume":"1227","author":"Kumar","year":"2023","journal-title":"Comput. Theor. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/ja01585a023","article-title":"Synthesis of some 4,6-substituted pyrazolo [3,4-d] pyrimidines","volume":"78","author":"Robins","year":"1956","journal-title":"J. Am. Chem. Soc."},{"issue":"1989","key":"10.1016\/j.bioorg.2023.107042_b0085","first-page":"41","article-title":"The purine path to chemotherapy","volume":"244","author":"Elion","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2023.107042_b0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2023.107042_b0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/13543776.2020.1811233","article-title":"Xanthine oxidase inhibitors: patent landscape and clinical development (2015\u20132020)","volume":"30","author":"Singh","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.107042_b0100","unstructured":"Duzallo | European Medicines Agency, (2020). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/duzallo (accessed May 20, 2022)."},{"key":"10.1016\/j.bioorg.2023.107042_b0105","unstructured":"Febuxostat Mylan, European Medicines Agency. (2022). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/febuxostat-mylan (accessed November 26, 2021)."},{"key":"10.1016\/j.bioorg.2023.107042_b0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjms.2018.11.018","article-title":"Allopurinol-induced Stevens-Johnson syndrome","volume":"357","author":"Gupta","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/106002809302700317","article-title":"Allopurinol hypersensitivity syndrome: a review","volume":"27","author":"Arellano","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bioorg.2023.107042_b0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425255.2014.904285","article-title":"Febuxostat: drug review and update","volume":"10","author":"Grewal","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2023.107042_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ardp.201200296","article-title":"Design and synthesis of aza-flavones as a new class of xanthine oxidase inhibitors","volume":"346","author":"Dhiman","year":"2013","journal-title":"Arch. Pharm. (weinheim)."},{"key":"10.1016\/j.bioorg.2023.107042_b0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s13730-014-0109-2","article-title":"Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis","volume":"3","author":"Ito","year":"2014","journal-title":"CEN Case Rep."},{"key":"10.1016\/j.bioorg.2023.107042_b0135","unstructured":"FDA Drug Safety Communication: FDA to evaluate increased risk of heart-related death and death from all causes with the gout medicine febuxostat (Uloric) | FDA, (2017). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-evaluate-increased-risk-heart-related-death-and-death-all-causes (accessed July 15, 2023)."},{"key":"10.1016\/j.bioorg.2023.107042_b0140","unstructured":"FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat) | FDA, (2019). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloric-febuxostat (accessed July 15, 2023)."},{"key":"10.1016\/j.bioorg.2023.107042_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100083","article-title":"Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study","volume":"1","author":"Kumar","year":"2021","journal-title":"Phytomed. Plus."},{"key":"10.1016\/j.bioorg.2023.107042_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0975-9476.59818","article-title":"An advocacy for Vaidya-Scientists in Ayurvedic research","volume":"1","author":"Vaidya","year":"2010","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.bioorg.2023.107042_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0025-7125(03)00073-7","article-title":"Ayurvedic medicine. Core concept, therapeutic principles, and current relevance","volume":"86","author":"Chopra","year":"2002","journal-title":"Med Clin North Am."},{"key":"10.1016\/j.bioorg.2023.107042_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1878-5085-5-19","article-title":"Bridging Ayurveda with evidence-based scientific approaches in medicine","volume":"5","author":"Patwardhan","year":"2014","journal-title":"EPMA J."},{"key":"10.1016\/j.bioorg.2023.107042_b0165","first-page":"2321","article-title":"Emerging role of herbal drugs in the management of diabetes mellitus","volume":"3","author":"Singh","year":"2015","journal-title":"World J. Pharmac. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0170","doi-asserted-by":"crossref","first-page":"971","DOI":"10.5530\/pj.2021.13.125","article-title":"Evaluation of xanthine oxidase inhibitory and antioxidant activities of three organs of idat (Cratoxylum glaucum korth.) and correlation with phytochemical content","volume":"13","author":"Juanda","year":"2021","journal-title":"Pharmacognosy J."},{"key":"10.1016\/j.bioorg.2023.107042_b0175","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/jssc.202100109","article-title":"C. ming Liu, Screening anti-gout compounds from Phellinus igniarius by ultrafiltration liquid chromatography mass spectrometry based on evaluation of an in vitro method combined with enzymatic reaction","volume":"44","author":"Wang","year":"2021","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153765","article-title":"Antihyperuricemia and antigouty arthritis effects of Persicaria capitata herba in mice","volume":"93","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2023.107042_b0185","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.48048\/tis.2022.2583","article-title":"Phytochemical and xanthine oxidase inhibitory activity in nypa fruticans wurmb, fruit extracts","volume":"19","author":"Moonrungsee","year":"2022","journal-title":"Trends Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.29228\/jrp.42","article-title":"Antioxidant, xanthine oxidase inhibitory and antibacterial activities of selected galactogogue Thai medicinal plant water and ethyl acetate extracts","volume":"25","author":"Seephonkai","year":"2021","journal-title":"J. Res. Pharmacy"},{"key":"10.1016\/j.bioorg.2023.107042_b0195","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/molecules26154472","article-title":"Phytochemical composition, antioxidant activity, and enzyme inhibitory activities (\u03b1-glucosidase, xanthine oxidase, and acetylcholinesterase) of musella lasiocarpa","volume":"26","author":"Li","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2023.107042_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.787125","article-title":"Extracts of andrographis paniculata (Burm.f.) nees leaves exert anti-gout effects by lowering uric acid levels and reducing monosodium urate crystal-induced inflammation","volume":"12","author":"Rahmi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.107042_b0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3897\/pharmacia.69.e91083","article-title":"Evaluation of xanthine oxidase inhibitory, antioxidative activity of five selected Papua medicinal plants and correlation with phytochemical content","volume":"69","author":"Dirgantara","year":"2022","journal-title":"Pharmacia."},{"key":"10.1016\/j.bioorg.2023.107042_b0210","first-page":"915","article-title":"Hydro-alcoholic extract of Ochradenus baccatus exhibits anti-oxidative and anti-inflammatory properties and inhibits enzyme of uric acid metabolism: implications for bioactive molecules","volume":"34","author":"Ullah","year":"2022","journal-title":"Emir. J. Food Agric."},{"key":"10.1016\/j.bioorg.2023.107042_b0215","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5530\/ijper.56.2.74","article-title":"Anti-inflammatory and anti-hyperuricemic effect of ficus benghalensis bark extract in raw 246.7 Cell Line","volume":"56","author":"Sabi","year":"2022","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.bioorg.2023.107042_b0220","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.13005\/bpj\/2496","article-title":"Antihyperuricemia activity of vanilla (vanilla planifolia andrews) fruits ethanol extract to male mice (Mus musculus L.)","volume":"15","author":"Nurcahyani","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.bioorg.2023.107042_b0225","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.3390\/nu14204421","article-title":"Anti-gouty arthritis and anti-hyperuricemia properties of sanghuangporus vaninii and inonotus hispidus in rodent models","volume":"14","author":"Sun","year":"2022","journal-title":"Nutrients."},{"key":"10.1016\/j.bioorg.2023.107042_b0230","first-page":"3184","article-title":"Acute oral toxicity assessment and anti-hyperuricemic activity of Alocasia longiloba extracts on Sprague-Dawley rats, Saudi","volume":"29","author":"Abdulhafiz","year":"2022","journal-title":"J. Biol. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2215083809666221213142127","article-title":"In vitro and in vivo investigations on anti-hyperuricemic activity of commercial preparations of Persicaria minor (Biokesum\u00ae) and Eurycoma longifolia (Physta\u00ae)","volume":"9","author":"Chinnappan","year":"2023","journal-title":"Curr. Tradit. Med."},{"key":"10.1016\/j.bioorg.2023.107042_b0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/12298093.2023.2176020","article-title":"In vitro \u03b1-amylase, \u03b1-glucosidase, pancreatic lipase, xanthine oxidase inhibiting activity of agaricus bisporus extracts","volume":"51","author":"Kim","year":"2023","journal-title":"Mycobiology."},{"key":"10.1016\/j.bioorg.2023.107042_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105485","article-title":"Cyclocarya paliurus leaves alleviate hyperuricemic nephropathy via modulation of purine metabolism, antiinflammation, and antifibrosis","volume":"103","author":"Gui","year":"2023","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.bioorg.2023.107042_b0250","first-page":"1","article-title":"Anticonvulsant potential of Grewia tiliaefolia in pentylenetetrazole induced epilepsy: insights from in vivo and in silico studies","volume":"1","author":"Rajput","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bioorg.2023.107042_b0255","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41598-023-29446-7","article-title":"Neuroprotective activity of novel phenanthrene derivative from Grewia tiliaefolia by in vitro and in silico studies","volume":"13","author":"Rajput","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.107042_b0260","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/cbdd.13437","article-title":"Natural compounds with xanthine oxidase inhibitory activity: A review","volume":"93","author":"Mehmood","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2023.107042_b0265","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.bcp.2013.08.011","article-title":"3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout","volume":"86","author":"L\u00fc","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.107042_b0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0031-9422(01)00176-5","article-title":"Glycosides and xanthine oxidase inhibitors from Conyza bonariensis","volume":"58","author":"Kong","year":"2001","journal-title":"Phytochemistry."},{"key":"10.1016\/j.bioorg.2023.107042_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104018","article-title":"New prenylflavonol glycosides with xanthine oxidase inhibitory activity from the leaves of Cyclocarya paliurus","volume":"101","author":"Ye","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128475","article-title":"Insights from multispectral and molecular docking investigation on the xanthine oxidase inhibition by 1,4-dicaffeoylquinic acid","volume":"1219","author":"Cao","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/molecules26010122","article-title":"Phloroglucinol derivatives from dryopteris crassirhizoma as potent xanthine oxidase inhibitors","volume":"26","author":"Yuk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.107042_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129772","article-title":"Insights into the inhibitory mechanism of purpurogallin on xanthine oxidase by multiple spectroscopic techniques and molecular docking","volume":"1228","author":"Wang","year":"2021","journal-title":"J .Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.129068","article-title":"Exploring the potential of novel xanthine oxidase inhibitory peptide (ACECD) derived from Skipjack tuna hydrolysates using affinity-ultrafiltration coupled with HPLC\u2013MALDI-TOF\/TOF-MS","volume":"347","author":"Zhong","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0300","doi-asserted-by":"crossref","first-page":"12503","DOI":"10.1039\/D1FO02719K","article-title":"Isorhamnetin, the xanthine oxidase inhibitor from: Sophora japonica, ameliorates uric acid levels and renal function in hyperuricemic mice","volume":"12","author":"Wang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.bioorg.2023.107042_b0305","doi-asserted-by":"crossref","first-page":"10306","DOI":"10.3390\/app112110306","article-title":"Identification of scopoletin and chlorogenic acid as potential active components in sunflower calathide enzymatically hydrolyzed extract towards hyperuricemia","volume":"11","author":"Dai","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0310","first-page":"316","article-title":"Two new seco-abietanoids with xanthine oxidase inhibitory activity from Cryptomeria japonica D. Don","volume":"16","author":"Chang","year":"2022","journal-title":"Records Nat. Products"},{"key":"10.1016\/j.bioorg.2023.107042_b0315","first-page":"1","article-title":"Antihyperuricemic effect of dendropanax morbifera leaf extract in rodent models","volume":"2021","author":"Lee","year":"2021","journal-title":"Evidence-Based Complem. Alternative Med."},{"key":"10.1016\/j.bioorg.2023.107042_b0320","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5530\/pj.2021.13.148","article-title":"Sukardiman, xanthine oxidase inhibition activity and ADMET properties of terap (artocarpus odoratissimus blanco) leaves metabolites: phytochemical screening and in silico studies","volume":"13","author":"Naspiah","year":"2021","journal-title":"Pharmacognosy J."},{"key":"10.1016\/j.bioorg.2023.107042_b0325","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pca.3057","article-title":"Rapid characterisation of xanthine oxidase inhibitors from the flowers of Chrysanthemum morifolium Ramat. Using metabolomics approach","volume":"33","author":"Loh","year":"2022","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.bioorg.2023.107042_b0330","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3390\/pharmaceutics14101982","article-title":"Xanthine oxidase inhibitory activity and chemical composition of pistacia chinensis leaf essential oil","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.bioorg.2023.107042_b0335","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/pr9112065","article-title":"Standardization of diploid codonopsis laceolata root extract as an anti-hyperuricemic source","volume":"9","author":"Song","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.bioorg.2023.107042_b0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.phytol.2021.03.010","article-title":"Erodium birandianum Ilarslan & Yurdak. shows anti-gout effect through xanthine oxidase inhibition: combination of in vitro and in silico techniques and profiling of main components by LC-Q-ToF-MS","volume":"43","author":"Baki Kekilli","year":"2021","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.bioorg.2023.107042_b0345","first-page":"291","article-title":"Evaluating the in vitro activity of depsidones from Usnea subfloridana Stirton as key enzymes involved in inflammation and gout","volume":"27","author":"Nguyen","year":"2021","journal-title":"Pharmaceut. Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0350","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11694-021-00811-2","article-title":"Optimization of extraction of flavonoids from shallot skin using response surface methodology based on multiple linear regression and artificial neural network and evaluation of its xanthine oxidase inhibitory activity","volume":"15","author":"Nguyen Thu","year":"2021","journal-title":"J. Food Measure. Characteriz."},{"key":"10.1016\/j.bioorg.2023.107042_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104937","article-title":"Hispidin, Harmaline, and Harmine as potent inhibitors of bovine xanthine oxidase: Gout treatment, in vitro, ADMET prediction, and SAR studies","volume":"112","author":"Linani","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0360","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijbiomac.2022.05.188","article-title":"The inhibitory kinetics and mechanism of quercetin-3-O-rhamnoside and chlorogenic acid derived from Smilax china L. EtOAc Fraction on Xanthine Oxidase","volume":"213","author":"Li","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2023.107042_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2022.101711","article-title":"In vitro xanthine oxidase inhibitory properties of Flos Sophorae Immaturus and potential mechanisms","volume":"47","author":"Li","year":"2022","journal-title":"Food Biosci."},{"key":"10.1016\/j.bioorg.2023.107042_b0370","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/foods11070968","article-title":"Vanillic acid as a promising xanthine oxidase inhibitor: extraction from amomum villosum lour and biocompatibility improvement via extract nanoemulsion","volume":"11","author":"Zhou","year":"2022","journal-title":"Foods."},{"key":"10.1016\/j.bioorg.2023.107042_b0375","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3897\/pharmacia.69.e77740","article-title":"Inhibitory effects of Moringa oleifera leaves extract on xanthine oxidase activity from bovine milk","volume":"69","author":"Natsir","year":"2022","journal-title":"Pharmacia."},{"key":"10.1016\/j.bioorg.2023.107042_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132100","article-title":"In vitro inhibitory effects of polyphenols from Tartary buckwheat on xanthine oxidase: identification, inhibitory activity, and action mechanism","volume":"379","author":"Li","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0385","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1039\/D2FO02068H","article-title":"Hypouricemic effect of gallic acid, a bioactive compound from Sonneratia apetala leaves and branches, on hyperuricemic mice","volume":"13","author":"Jiang","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.bioorg.2023.107042_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105130","article-title":"Protective effects of Cyclocarya paliurus on hyperuricemia and urate-induced inflammation","volume":"94","author":"Zhu","year":"2022","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.bioorg.2023.107042_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100197","article-title":"Accumulation of betacyanin in Hylocereus undatus rind: Pigment stability analysis and its role in xanthine oxidase inhibition","volume":"2","author":"Dey","year":"2022","journal-title":"Phytomedicine Plus."},{"key":"10.1016\/j.bioorg.2023.107042_b0400","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/molecules24050889","article-title":"Isolation and purification of bioactive compounds from the stem bark of jatropha podagrica","volume":"24","author":"Minh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.107042_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106097","article-title":"Novel xanthine oxidase inhibitory peptides derived from whey protein: identification, in vitro inhibition mechanism and in vivo activity validation","volume":"128","author":"Qi","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2023.102645","article-title":"Phytochemical profiling, in vitro and in vivo xanthine oxidase inhibition and antihyperuricemic activity of Christia vespertilionis leaf","volume":"48","author":"Endrini","year":"2023","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.bioorg.2023.107042_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105378","article-title":"Identification of coniferyl ferulate as the bioactive compound behind the xanthine oxidase inhibitory activity of Chuanxiong Rhizome","volume":"100","author":"Wang","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bioorg.2023.107042_b0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/foods12030573","article-title":"Potent xanthine oxidase inhibitory activity of constituents of agastache rugosa (Fisch. and C.A.Mey.) kuntze","volume":"12","author":"Yuk","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.bioorg.2023.107042_b0425","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.sajb.2023.01.037","article-title":"Metabolic bioprofiling for discovering xanthine oxidase inhibitors from Glycyrrhiza glabra root solvents fractions using orthogonal separation modalities coupled with chemometry","volume":"154","author":"Mahrous","year":"2023","journal-title":"South Afr. J. Botany"},{"key":"10.1016\/j.bioorg.2023.107042_b0430","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1080\/14786419.2022.2132499","article-title":"Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro study","volume":"37","author":"Kumar","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2023.107042_b0435","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.48048\/tis.2023.4201","article-title":"In vitro xanthine oxidase inhibitory activity of Morinda citrifolia L. (Noni) leaf and identification of its xanthine oxidase inhibitors","volume":"20","author":"Thipwong","year":"2022","journal-title":"Trends Sci."},{"key":"10.1016\/j.bioorg.2023.107042_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106405","article-title":"Pharmacological evaluation of a novel skeleton compound isobavachin (4\u2032,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1\/GLUT9 and xanthine oxidase inhibitory activity","volume":"133","author":"Zhao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/23808993.2016.1176527","article-title":"Technological advances in precision medicine and drug development","volume":"1","author":"Maggi","year":"2016","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.bioorg.2023.107042_b0450","article-title":"Vitamins and minerals fortified emulsion of omega-3 fatty acids for the management of preterm birth: In-vitro, in-silico, and in-vivo studies","volume":"83","author":"Thakur","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioorg.2023.107042_b0455","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2023.107042_b0460","unstructured":"C. Kaur, S. Dhiman, H. Singh, M. Kaur, S. Bhagat, M. Gupta, S. Sharma, P. Mohinder, S. Bedi, Synthesis, screening and docking studies of benzochromone derivatives as xanthine oxidase inhibitors, J. Chem. Pharm. Res. 7 (2015) 127\u2013136. www.jocpr.com (accessed November 11, 2023)."},{"key":"10.1016\/j.bioorg.2023.107042_b0465","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/14756366.2014.961446","article-title":"Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors","volume":"30","author":"Virdi","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0470","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1039\/C8MD00512E","article-title":"Benzoflavone derivatives as potent antihyperuricemic agents","volume":"10","author":"Singh","year":"2018","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bioorg.2023.107042_b0475","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/13543776.2022.2130752","article-title":"Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001\u20132021)","volume":"32","author":"Bhagat","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.107042_b0480","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.bmc.2019.06.033","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids","volume":"27","author":"Singh","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0485","doi-asserted-by":"crossref","unstructured":"K. Kaur, N. Kumar, J.V. Singh, P.M.S. Bedi, H. Singh, Recent Development of Quinoline Derivatives as Anticancer Agents: 2015\u20132022, in: Interdisciplinary Cancer Research, Springer, Cham, 2023: pp. 1\u201334. https:\/\/doi.org\/10.1007\/16833_2023_125.","DOI":"10.1007\/16833_2023_125"},{"key":"10.1016\/j.bioorg.2023.107042_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136194","article-title":"A comprehensive review on thiazole based conjugates as anti-cancer agents","volume":"1292","author":"Rana","year":"2023","journal-title":"J Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0495","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3529875","article-title":"Molecular modelling based design and synthesis of donepezil like derivatives as acetylcholinesterase inhibitors","author":"Kumar","year":"2020","journal-title":"SSRN Electr. J."},{"key":"10.1016\/j.bioorg.2023.107042_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135354","article-title":"A comprehensive review on triazole based conjugates as acetylcholinesterase inhibitors: Design strategies, synthesis, biological activity, structure activity relationships, molecular docking studies","volume":"1284","author":"Gulati","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0505","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acschemneuro.1c00535","article-title":"Donepezil-inspired multitargeting indanone derivatives as effective anti-Alzheimer\u2019s Agents","volume":"13","author":"Singh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2023.107042_b0510","first-page":"3","article-title":"Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer","volume":"1","author":"Kumar","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2023.107042_b0515","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s11030-022-10537-y","article-title":"Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights","volume":"27","author":"Kumar","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2023.107042_b0520","doi-asserted-by":"crossref","first-page":"e2200033","DOI":"10.1002\/ardp.202200033","article-title":"Design, synthesis, and biological evaluation of isatin-indole-3-carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors","volume":"355","author":"Singh","year":"2022","journal-title":"Arch. Pharm. (weinheim)."},{"key":"10.1016\/j.bioorg.2023.107042_b0525","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.bmcl.2014.07.041","article-title":"Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors","volume":"24","author":"Singh","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107042_b0530","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1007\/s00044-015-1382-0","article-title":"Screening of a library of 4-aryl\/heteroaryl-4H-fused pyrans for xanthine oxidase inhibition: Synthesis, biological evaluation and docking studies","volume":"24","author":"Kaur","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.107042_b0535","first-page":"1","article-title":"Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFRwt and mutant EGFRT790M receptor tyrosine kinases","author":"Shah","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2023.107042_b0540","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00044-019-02461-y","article-title":"Thiazole-5-carboxylic acid derivatives as potent xanthine oxidase inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies","volume":"29","author":"Kaur","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.107042_b0545","doi-asserted-by":"crossref","first-page":"504","DOI":"10.22270\/jddt.v8i5.1894","article-title":"Computer aided drug design: an overview","volume":"8","author":"Surabhi","year":"2018","journal-title":"J. Drug Deliv. Therapeutics"},{"key":"10.1016\/j.bioorg.2023.107042_b0550","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13543776.2017.1261111","article-title":"An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011\u20132015)","volume":"27","author":"Ojha","year":"2017","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.107042_b0555","article-title":"Amide-based xanthine oxidase inhibitors bearing an N-(1-alkyl-3-cyano-1H-indol-5-yl) moiety: Design, synthesis and structure-activity relationship investigation","volume":"117","author":"Jian Zhang","year":"2021","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0560","article-title":"A possible covalent xanthine oxidase inhibitor TS10: Inhibition mechanism, metabolites identification and PDPK assessment","volume":"128","author":"Jian Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105321","article-title":"Design, synthesis and bioactive evaluation of geniposide derivatives for antihyperuricemic and nephroprotective effects","volume":"116","author":"Wang","year":"2021","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0570","article-title":"Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors","volume":"127","author":"Jian Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0575","article-title":"Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors","volume":"133","author":"Sen Hu","year":"2023","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104620","article-title":"Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition","volume":"107","author":"Joshi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0585","doi-asserted-by":"crossref","unstructured":"A.Y. Rashad, S.E. Kassab, H.G. Daabees, A.E. Abdel Moneim, S.A.F. Rostom, Febuxostat-based amides and some derived heterocycles targeting xanthine oxidase and COX inhibition. Synthesis, in vitro and in vivo biological evaluation, molecular modeling and in silico ADMET studies, Bioorg Chem. 113 (2021) 104948. https:\/\/doi.org\/10.1016\/J.BIOORG.2021.104948.","DOI":"10.1016\/j.bioorg.2021.104948"},{"key":"10.1016\/j.bioorg.2023.107042_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133963","article-title":"In-silico docking, synthesis, structure analysis, DFT calculations, energy frameworks, and pharmacological intervention of [1,3,4]-thiadiazoles analogous as XO inhibitor and on multiple molecular inflammatory targets COX and LOX","volume":"1270","author":"Zabiulla","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106320","article-title":"Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction","volume":"131","author":"Yang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132567","article-title":"Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods","volume":"1256","author":"Zhu","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105181","article-title":"N-(3-cyano-1H-indol-5-yl)isonicotinamide and N-(3-cyano-1H-indol-5-yl)-1H-benzo[d]imidazole-5-carboxamide derivatives: Novel amide-based xanthine oxidase inhibitors","volume":"115","author":"Tu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128060","article-title":"Novel 1,2,3-triazole compounds: synthesis, In vitro xanthine oxidase inhibitory activity, and molecular docking studies","volume":"1211","author":"Tan","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107042_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103564","article-title":"Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: design, synthesis and biological evaluation","volume":"95","author":"Gao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104654","article-title":"Synthesis, inhibition properties against xanthine oxidase and molecular docking studies of dimethyl N-benzyl-1H-1,2,3-triazole-4,5-dicarboxylate and (N-benzyl-1H-1,2,3-triazole-4,5-diyl)dimethanol derivatives","volume":"108","author":"Yagiz","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0625","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/157340607780059521","article-title":"Pharmacophore modeling in drug discovery and development: an overview","volume":"3","author":"Khedkar","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105149","article-title":"Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer\u2019s disease agents","volume":"114","author":"Gao","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107042_b0635","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1080\/14786419.2021.2013212","article-title":"Discovery of potent inhibitors for M pro enzyme of SARS-COV2 by multi-stage in-silico screening of Alkannin\/shikonin","volume":"36","author":"Kumar","year":"2022","journal-title":"Nat Prod Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823007034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823007034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:54:36Z","timestamp":1758617676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823007034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":127,"alternative-id":["S0045206823007034"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107042","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020\u20132023)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107042"}}